STOCK TITAN

Erasca (ERAS) director receives grant of 29,888 stock options at $16.01

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Erasca, Inc. director Valerie Denise Harding received a stock option grant covering 29,888 shares of Common Stock. The options have an exercise price of $16.01 per share and expire on June 26, 2036.

All 29,888 options vest on June 26, 2027, provided she remains in continuous service with the company through that date. Following this grant, she holds 29,888 derivative securities directly, reflecting a routine, compensation-related award rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Start Valerie Denise Harding
Role null
Type Security Shares Price Value
Grant/Award Stock option (right to buy) 29,888 $0.00 --
Holdings After Transaction: Stock option (right to buy) — 29,888 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Option grant size 29,888 options Stock option grant reported June 26, 2026
Underlying shares 29,888 shares Common Stock underlying granted options
Exercise price $16.01 per share Conversion or exercise price of options
Vesting date June 26, 2027 100% of options vest on this date
Expiration date June 26, 2036 Option expiration
Post-grant derivative holdings 29,888 options Total derivative securities following transaction
Stock option (right to buy) financial
"security_title: "Stock option (right to buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
continuous service financial
"subject to the Reporting Person's continuous service to the Issuer"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Start Valerie Denise Harding

(Last)(First)(Middle)
C/O ERASCA, INC.
3115 MERRYFIELD ROW, SUITE 300

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Erasca, Inc. [ ERAS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock option (right to buy)$16.0106/26/2026A29,88806/26/2027(1)06/26/2036Common Stock29,888$029,888D
Explanation of Responses:
1. 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date.
/s/ Ebun S. Garner, as Attorney-in-Fact06/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Erasca (ERAS) director Valerie Denise Harding report in this Form 4?

She reported receiving a stock option grant for 29,888 shares of Erasca Common Stock. The options are a compensation-related award, not an open-market trade, and give her the right to buy shares at a fixed exercise price in the future.

How many Erasca (ERAS) shares are covered by Valerie Denise Harding’s new options?

The grant covers options on 29,888 shares of Erasca Common Stock. These options were awarded as a single grant and represent her total derivative holdings reported following the transaction on June 26, 2026.

What is the exercise price of Valerie Denise Harding’s Erasca (ERAS) stock options?

The options have an exercise price of $16.01 per share. This means she can buy Erasca Common Stock at $16.01 per share once the options vest, regardless of the market price at that time.

When do Valerie Denise Harding’s Erasca (ERAS) stock options vest and expire?

All 29,888 options vest on June 26, 2027, if she remains in continuous service to Erasca through that date. The options then remain exercisable until their expiration on June 26, 2036, subject to plan and agreement terms.

Is Valerie Denise Harding’s Form 4 for Erasca (ERAS) a buy or a sale of stock?

The Form 4 reports an acquisition through a grant of stock options, not a market buy or sale. The transaction code "A" reflects a grant or award, so no shares were bought or sold in the open market.

How many Erasca (ERAS) derivative securities does Valerie Denise Harding hold after this grant?

After the transaction, she holds 29,888 derivative securities directly, all from this stock option grant. These options each relate to one share of Erasca Common Stock, giving her potential future ownership if she exercises them.